September 29, 2015
During its first year of operations, Vtesse advances lead program into late-stage, pivotal trial and launches www.theNPCstudy.com- Goal is to establish a clear foundational data set on the safety and efficacy of VTS-270 for treatment of NPCGAITHERSBURG, Md., Sept. 28, 2015 /PRNewswire/ -- Vtesse, Inc. today announced that the first three patients have been screened for inclusion in...
CERAMENTT with Gentamicin Shown to Decrease Recurrence of Infection and Increase Bone FormationLund, Sweden, (PRNEWSWIRE) September 24, 2015 - BONESUPPORTT, an emerging leader in injectable bone substitutes for orthopedic trauma, bone infections and instrument augmentation related to orthopedic surgery, today announced the presentation of new clinical data with the Company's platform bone void filler, CERAMENTT...


Danish researchers provide proof: Caesarean sections can lead to asthma and allergies
12. November 2020
Brand-new medical treatment for cocaine addiction
10. November 2020
90 million to 18 Talented Researchers
19. October 2020


Lundbeckfonden Ventures

Lundbeckfonden Emerge